Table 2.
Percentage of patients per APACHE II admission category
| Medical population | Surgical population | |||||||
|---|---|---|---|---|---|---|---|---|
| Total n = 1,339 |
≤6.6 mmol/L n = 268 |
'Safe range' n = 804 |
≥8.5 mmol/L n = 267 |
Total n = 4,489 |
≤6.9 mmol/L n = 898 |
'Safe range' n = 2,694 |
≥9.5 mmol/L n = 897 |
|
| Cardiovascular | 18.0 | 11.6 | 19.9 | 18.7 | 88.2 | 81.0 | 88.3 | 95.1 |
| Sepsis | 16.5 | 22.8 | 16.0 | 11.6 | 1.2 | 2.8 | 1.0 | 0.1 |
| After cardiac arrest | 21.6 | 11.9 | 21.5 | 31.5 | 0.2 | 0.6 | 0.1 | 0.1 |
| Gastrointestinal | 4.3 | 4.1 | 4.2 | 4.9 | 5.3 | 8.7 | 5.0 | 2.8 |
| Hematological | 0.6 | 0.7 | 0.7 | 0 | 0.2 | 0.4 | 0.1 | 0.1 |
| Renal | 1.9 | 1.5 | 1.0 | 5.2 | 0.3 | 0.6 | 0.2 | 0.1 |
| Metabolic | 3.6 | 3.0 | 2.7 | 6.7 | 0.2 | 0.1 | 0.2 | 0.1 |
| Neurological | 11.5 | 18.3 | 10.3 | 8.2 | 0.9 | 1.1 | 1.0 | 0.3 |
| Respiratory | 22.0 | 26.1 | 23.5 | 13.1 | 3.6 | 4.8 | 4.0 | 1.2 |
The 'safe range' refers to the mean glucose levels associated with the lowest mortality rates: 6.7 to 8.4 mmol/L in the medical cohort and 7.0 to 9.4 mmol/L in the surgical cohort. APACHE II, Acute Physiology and Chronic Health Evaluation II.